SynthesisPathogens (Basel, Switzerland)2025
Fungi-Based Bioproducts: A Review in the Context of One Health.
Synthesis in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Genome-wide exploration of biosynthetic gene clusters and their association with virulence in the entomopathogenic fungus Beauveria.Functional & integrative genomics · 2026Article
- Towards a Novel Biocontrol Strategy: High Performance of Optimised Cell Wall-Degrading Enzymes Secreted by Escovopsis primorosea LBM 277.Environmental microbiology reports · 2026Article
- Conserved gene clusters in entomopathogenic filamentous fungi.Genetics and molecular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Entomopathogenic fungus-based biopesticides are an excellent alternative to synthetic pesticides and are widely used in insect pest control. With the transformations of the agri-food system, it is important to consider the One Health approach, which recognizes that health threats are shared at the interface between people, animals, plants, and the environment. The safety and environmental impact of fungi-based insecticides should be assessed comprehensively, taking into account not only their effects on non-target organisms and human health but also their environmental fate. This includes how these substances degrade, persist, or dissipate in soil, water, and air and their potential to bioaccumulate or leach into groundwater. Such assessments are essential to ensure that their long-term use does not pose unintended risks to ecosystems or public health. This systematic review aims to identify and analyze available studies on the potential One Health hazards associated with fungal biopesticides. A total of 134 articles were selected: 84 bioassay articles (63%), 36 case reports (27%), 10 field studies (7%), and 4 other types of studies (3%). Of these articles, 59 were studies on vertebrate animals and 65 studies on invertebrate animals, 6 studies on diverse organisms, 2 studies focused specifically on risk assessment for non-target organisms in the environment, while 2 other studies looked at the toxicological hazards associated with human exposure to the metabolites of the fungus present in air. The United States had the highest number of publications (33).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.